12-Month Lobbying Summary - In-house Corporation

Return to 12-Month Lobbying Activity Search Results

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Registration Summary

Active - Last Updated: 2023-09-01

Who is lobbying?

sanofi-aventis Canada Inc. (Address & business activities)

Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Received government funding or funding expected in current financial year

Business Relationships

sanofi-aventis Canada Inc. is a subsidiary of the following parent companies

Sanofi (Address information)

Beneficiaries of the Lobbying Activity

sanofi-aventis Canada Inc. has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Sanofi Consumer Health Inc./Sanofi Santé Grand Public Inc. (Address information)
sanofi-Pasteur Ltd. (Address information)

What is being lobbied?

Subject Matters

Aboriginal Affairs
Health
Industry
Intellectual Property
Internal Trade
International Relations
International Trade
Justice and Law Enforcement
Regional Development
Research and Development
Science and Technology

Subject Matter Details

Legislative Proposal, Bill or Resolution

Comprehensive Economic and Trade Agreement Negotiations as it relates to the protection of intellectual property rights.
Patent Act as it relates to the regulation of intellectual property for therapeutic products

Legislative Proposal, Bill or Resolution, Regulation

Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products

Policies or Program

Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
Innovation, Science and Economic Development Canada , particularly with respect to the life sciences priority under the S&T Strategy
Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees
Policy or program: National pharmacare with respect to the coordinaton of drug plan policies and programs
Research and Development Legislative Proposal, Policy or Program, with respect to the strategy on innovation.

Regulation

Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations.
Patented Medicines Prices Review Board with respect to amendments to the guidelines for the regulation of pricing of patented drug products patentees

Who is being lobbied?

Government Institutions

Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Infrastructure Canada (INFC)
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
National Defence (DND)
National Research Council (NRC)
Natural Resources Canada (NRCan)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Services and Procurement Canada (PSPC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)
Veterans Affairs Canada (VAC)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Grass-roots communication
Written communication
Oral communication
Arrange one or more meetings

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Stephanie Veyrun-Manetti, President & CEO | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Carrie McElroy, Head Market Access & Public Affairs | No public offices held

Registration number: 951483-5180
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

No monthly communications reports have been submitted for the last 12 months.

View all monthly communication reports

Return to 12-Month Lobbying Activity Search Results

sanofi-aventis Canada Inc. - Address & business activities

Address:

1755 Steeles Avenue West
North York, ON M2R 3T4
Canada

Telephone number: 416-667-2700

Contact information in previous versions
- 2905 Place Louis-R. Renaud
  Laval, QC H7V 0A3
  Canada
  
  Telephone number: 514-956-6200
- 2905 Place Louis-R. Renaud
  Laval, QC H7V 0A3
  Canada
  
  Telephone number: 905-520-2539
- 2905 Place Louis-R. Renaud
  Laval, QC H7V 0A3
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149
- 2905 Place Louis-R. Renaud
  Laval, QC H7V 0A3
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149
- 2905 Place Louis-R. Renaud
  Laval, QC H7V 0A3
  Canada
  
  Telephone number: 514-331-9220
- 2150 St-Elzear West
  Laval, QC H7L 4A8
  Canada
  
  Telephone number: 514-331-9220
- 2150 St-Elzear West
  Laval, QC H7L 4A8
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149
- 2150, blvd. St-Elzear West
  Laval, QC H7L 4A8
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149
- 2150, blvd. St-Elzéar o.
  Laval, QC H7L 4A8
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149
- 2150 boul. St-Elzear o.
  Laval, QC H7L 4A8
  Canada
  
  Telephone number: 514-956-6246
  
  Fax number: 514-339-5149

Description of activities:
Innovative pharmaceutical company - marketing and sales of drugs, medical devices, natural health products, cosmetics and offer of therapeutic solutions.

Descriptions of the corporation's activity in previous versions:
- Innovative pharmaceutical company (manufacturing, marketing and sales)
- Compagnie de recherche pharmaceutique (production, vente et commercialisation)
- Compagnie de recherche pharmaceutique (Manufacture et ventes)
- sanofi-aventis est une compagnie de recherche et manufacture pharmaceutique

Date Modified:: 2024-04-04

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

Who is lobbying?

sanofi-aventis Canada Inc. (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

sanofi-aventis Canada Inc. is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

sanofi-aventis Canada Inc. has the following subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Regulation

Who is being lobbied?

Government Institutions

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

What oral and arranged communications have taken place?

12-Month Lobbying Summary - In-house Corporation

sanofi-aventis Canada Inc. / Stephanie Veyrun-Manetti, President and Chief Executive Officer (CEO)

sanofi-aventis Canada Inc. (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

sanofi-aventis Canada Inc. is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

sanofi-aventis Canada Inc. has the following subsidiaries that could have a direct interest in the outcome of the undertaking

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Regulation

Government Institutions

Communication techniques

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

sanofi-aventis Canada Inc. - Address & business activities

sanofi-Pasteur Ltd.

Sanofi Consumer Health Inc. / Sanofi Santé Grand Public Inc.

Sanofi